PURPOSE: The number of cancer survivors is increasing, and patients with cancer often experience long-lasting consequences of cancer and its treatment. Because of the variety of health problems and high prevalence of comorbidity, primary care physicians (PCPs) seem obvious candidates to take care of these patients, and insight into primary health care (PHC) use of cancer survivors is needed. We aimed to find determinants for PHC use in cancer survivors. METHODS: Using data from the Netherlands Information Network of Primary Care, we determined the volume of PHC use in 1,256 adult patients with breast cancer, 503 patients with prostate cancer, and 487 patients with colorectal cancer 2 to 5 years after diagnosis and compared this with age- and sex-matched controls without cancer from the same practice. We also examined whether age, comorbidity, and time since diagnosis were related to PHC use. RESULTS: The mean annual number of primary care contacts was increased compared with control patients by 24% in patients with breast cancer (P<.001) and by 33% in patients with prostate cancer (P<.001). This difference remained constant between 2 and 5 years after diagnosis. In patients with colon cancer, the difference with controls tended to decrease with age (12% per 10 years; P=.005). CONCLUSION: PHC use is significantly increased 2 to 5 years after diagnosis of cancer, especially in younger patients without a chronic disease. Given the expected increase in cancer survivors, PCPs should prepare themselves for this increasing amount of aftercare. The development of multidisciplinary care standards for cancer survivors could be helpful.
PURPOSE: The number of cancer survivors is increasing, and patients with cancer often experience long-lasting consequences of cancer and its treatment. Because of the variety of health problems and high prevalence of comorbidity, primary care physicians (PCPs) seem obvious candidates to take care of these patients, and insight into primary health care (PHC) use of cancer survivors is needed. We aimed to find determinants for PHC use in cancer survivors. METHODS: Using data from the Netherlands Information Network of Primary Care, we determined the volume of PHC use in 1,256 adult patients with breast cancer, 503 patients with prostate cancer, and 487 patients with colorectal cancer 2 to 5 years after diagnosis and compared this with age- and sex-matched controls without cancer from the same practice. We also examined whether age, comorbidity, and time since diagnosis were related to PHC use. RESULTS: The mean annual number of primary care contacts was increased compared with control patients by 24% in patients with breast cancer (P<.001) and by 33% in patients with prostate cancer (P<.001). This difference remained constant between 2 and 5 years after diagnosis. In patients with colon cancer, the difference with controls tended to decrease with age (12% per 10 years; P=.005). CONCLUSION: PHC use is significantly increased 2 to 5 years after diagnosis of cancer, especially in younger patients without a chronic disease. Given the expected increase in cancer survivors, PCPs should prepare themselves for this increasing amount of aftercare. The development of multidisciplinary care standards for cancer survivors could be helpful.
Authors: Crystal S Denlinger; Robert W Carlson; Madhuri Are; K Scott Baker; Elizabeth Davis; Stephen B Edge; Debra L Friedman; Mindy Goldman; Lee Jones; Allison King; Elizabeth Kvale; Terry S Langbaum; Jennifer A Ligibel; Mary S McCabe; Kevin T McVary; Michelle Melisko; Jose G Montoya; Kathi Mooney; Mary Ann Morgan; Tracey O'Connor; Electra D Paskett; Muhammad Raza; Karen L Syrjala; Susan G Urba; Mark T Wakabayashi; Phyllis Zee; Nicole McMillian; Deborah Freedman-Cass Journal: J Natl Compr Canc Netw Date: 2014-01 Impact factor: 11.908
Authors: Borsika A Rabin; Jennifer L Ellis; John F Steiner; Larissa Nekhlyudov; Eric J Feuer; Benjamin F Hankey; Laurie Cynkin; Elizabeth Bayliss Journal: J Natl Cancer Inst Monogr Date: 2014-11
Authors: Tara Sanft; Crystal S Denlinger; Saro Armenian; K Scott Baker; Gregory Broderick; Wendy Demark-Wahnefried; Debra L Friedman; Mindy Goldman; Melissa Hudson; Nazanin Khakpour; Divya Koura; Robin M Lally; Terry S Langbaum; Allison L McDonough; Michelle Melisko; Kathi Mooney; Halle C F Moore; Javid J Moslehi; Tracey O'Connor; Linda Overholser; Electra D Paskett; Lindsay Peterson; William Pirl; M Alma Rodriguez; Kathryn J Ruddy; Sophia Smith; Karen L Syrjala; Amye Tevaarwerk; Susan G Urba; Phyllis Zee; Nicole R McMillian; Deborah A Freedman-Cass Journal: J Natl Compr Canc Netw Date: 2019-07-01 Impact factor: 11.908
Authors: Lori Mandelzweig; Angela Chetrit; Tova Amitai; Bernice Oberman; Nava Siegelmann Danieli; Barbara Silverman; Siegal Sadetzki Journal: Support Care Cancer Date: 2015-07-21 Impact factor: 3.603
Authors: Laura A M Duineveld; Thijs Wieldraaijer; Kristel M van Asselt; Ineke C Nugteren; Sandra C Donkervoort; Anthony W H van de Ven; Anke B Smits; Anna A W van Geloven; Willem A Bemelman; Frederique H Beverdam; Willem F van Tets; Marc J P M Govaert; Judith E Bosmans; Irma M Verdonck-de Leeuw; Cornelia F van Uden-Kraan; Henk C P M van Weert; Jan Wind Journal: Trials Date: 2015-06-26 Impact factor: 2.279
Authors: Marianne Heins; François Schellevis; Mieke Rijken; Gé Donker; Lucas van der Hoek; Joke Korevaar Journal: Scand J Prim Health Care Date: 2013-12 Impact factor: 2.581